SaveLimited coverage of weight-loss drugs could fuel health inequitiesKey takeaways:Some health insurance companies are limiting coverage of pharmacologic obesity treatments. The AMA has adopted a policy in support of insurance coverage parity for evidence-based weight-loss medications “without exclusions or additional carve-outs,” the organization recently announced. The new policy comes amid reports that some health insurance companies are enforcing stricter coverage requirements for weight-loss medications, and some employers are stopping their coverage altogether, according to reporting by STAT. Some health insurance companies are limiting coverage of pharmacologic obesity treatments, like GLP-1 receptor agonists. Weight-loss medications are also limited in government programs.

Source: Wall Street Journal December 20, 2023 20:15 UTC